Cochlear Gestione

Gestione criteri di controllo 4/4

Cochlear's Il CEO è Dig Howitt, nominato in Jul2017, e ha un mandato di 7.08 anni. la retribuzione annua totale è A$ 6.45M, composta da 32.1% di stipendio e 67.9% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.083% delle azioni della società, per un valore di A$ 16.63M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 7.1 anni e 5.7 anni.

Informazioni chiave

Dig Howitt

Amministratore delegato

AU$6.4m

Compenso totale

Percentuale dello stipendio del CEO	32.1%
Mandato del CEO	7.3yrs
Proprietà del CEO	0.09%
Durata media del management	7.3yrs
Durata media del Consiglio di amministrazione	4.8yrs

Aggiornamenti recenti sulla gestione

Recent updates

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Dig Howitt rispetto agli utili di Cochlear?
Data	Compenso totale	Stipendio	Guadagni aziendali
Jun 30 2024	AU$6m	AU$2m	AU$357m
Mar 31 2024	n/a	n/a	AU$354m
Dec 31 2023	n/a	n/a	AU$350m
Sep 30 2023	n/a	n/a	AU$326m
Jun 30 2023	AU$6m	AU$2m	AU$301m
Mar 31 2023	n/a	n/a	AU$281m
Dec 31 2022	n/a	n/a	AU$261m
Sep 30 2022	n/a	n/a	AU$275m
Jun 30 2022	AU$5m	AU$2m	AU$289m
Mar 31 2022	n/a	n/a	AU$273m
Dec 31 2021	n/a	n/a	AU$257m
Sep 30 2021	n/a	n/a	AU$291m
Jun 30 2021	AU$5m	AU$2m	AU$324m
Mar 31 2021	n/a	n/a	AU$82m
Dec 31 2020	n/a	n/a	-AU$160m
Sep 30 2020	n/a	n/a	-AU$199m
Jun 30 2020	AU$3m	AU$2m	-AU$238m
Mar 31 2020	n/a	n/a	AU$34m
Dec 31 2019	n/a	n/a	AU$306m
Sep 30 2019	n/a	n/a	AU$291m
Jun 30 2019	AU$4m	AU$2m	AU$277m
Mar 31 2019	n/a	n/a	AU$270m
Dec 31 2018	n/a	n/a	AU$264m
Sep 30 2018	n/a	n/a	AU$255m
Jun 30 2018	AU$3m	AU$2m	AU$246m

Compensazione vs Mercato: La retribuzione totale di Dig ($USD 4.31M ) è circa la media per le aziende di dimensioni simili nel mercato Australian ($USD 4.21M ).

Compensazione vs guadagni: La retribuzione di Dig è stata coerente con le performance aziendali dell'ultimo anno.

AMMINISTRATORE DELEGATO

Dig Howitt (57 yo)

7.3yrs

Mandato

AU$6,446,856

Compensazione

Mr. Diggory William Howitt, also known as Dig, BE (Hons), MBA has been President of Cochlear Limited since July 31, 2017 and its Chief Executive Officer and Managing Director since January 3, 2018. Mr. How...

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Diggory Howitt	CEO, MD	7.3yrs	AU$6.45m	0.094% A$ 17.4m
Stuart Sayers	Chief Financial Officer	8.4yrs	AU$2.46m	0.0052% A$ 968.3k
Jan Janssen	Chief Technology Officer	6.9yrs	AU$2.66m	0.0093% A$ 1.7m
Karen O'Driscoll	Chief Information Officer	1.8yrs	Nessun dato	Nessun dato
Kristina Devon	Vice President of Investor Relations	no data	Nessun dato	Nessun dato
Rob McGrory	Group General Counsel & Company Secretary	1.1yrs	Nessun dato	Nessun dato
Jennifer Stevenson	VP of Corporate Communications & Brand	no data	Nessun dato	Nessun dato
Dean Phizacklea	Senior Vice President of Global Strategic Marketing	8.3yrs	Nessun dato	Nessun dato
Jennifer Hornery	Senior Vice President of Global People & Culture	7.8yrs	Nessun dato	Nessun dato
Greg Bodkin	Senior Vice President of Global Supply Chain	no data	Nessun dato	Nessun dato
Anthony Bishop	President of Asia Pacific & Latin America	no data	AU$1.45m	Nessun dato
Kimberley Simpson	Head of Group Tax	no data	Nessun dato	Nessun dato

7.3yrs

Durata media

Gestione esperta: Il team dirigenziale di COH è esperto e expertise (durata media dell'incarico 7.1 anni).

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Diggory Howitt	CEO, MD	6.9yrs	AU$6.45m	0.094% A$ 17.4m
Michael Daniell	Independent Non-Executive Director	4.8yrs	AU$295.72k	0.0025% A$ 459.1k
Catriona Deans	Independent Non-Executive Chairman of the Board	9.8yrs	AU$596.78k	0.0069% A$ 1.3m
Bruce Robinson	Independent Non-Executive Director	7.8yrs	AU$269.01k	0.0018% A$ 336.4k
Karen Lee Penrose	Non-Executive Independent Director	2.3yrs	AU$305.87k	0.0022% A$ 403.3k
Glen Boreham	Independent Non-Executive Director	9.8yrs	AU$293.36k	0.0046% A$ 854.9k
Michael J. Del Prado	Independent Non-Executive Director	2.8yrs	AU$314.99k	0.0014% A$ 267.6k
Christine McLoughlin	Independent Non-Executive Director	3.9yrs	AU$287.65k	0.0037% A$ 682.1k
Caroline Clarke	Non-Executive Director	less than a year	Nessun dato	Nessun dato

4.8yrs

Durata media

61yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di COH sono considerati esperti (durata media dell'incarico 5.7 anni).

Cochlear Gestione

Gestione criteri di controllo 4/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

Stu Sayers to Appoint as President, Asia Pacific & Latin America of Cochlear Limited, Effective from 1 January 2025

Cochlear Limited Appoints Caroline Clarke as Non-Executive Director, Effective from 2 September 2024

Cochlear Limited Announces Executive Changes

Cochlear Limited Announces Company Secretary Changes

Cochlear Limited Announces Andrew Denver, Non-Executive Director Intention to Retire At AGM to Be Held on 17 October 2023

Cochlear Limited, Annual General Meeting, Oct 17, 2023

Recent updates

Now 20% overvalued

Stu Sayers to Appoint as President, Asia Pacific & Latin America of Cochlear Limited, Effective from 1 January 2025

Upcoming dividend of AU$2.10 per share

Cochlear Limited Announces Ordinary Dividend for the Period of Six Months Ended June 30, 2024, Payable on October 10, 2024

Full year 2024 earnings released: EPS: AU$5.45 (vs AU$4.57 in FY 2023)

Cochlear Limited (ASX:COH) announces an Equity Buyback for AUD 75 million worth of its shares.

Cochlear Limited Appoints Caroline Clarke as Non-Executive Director, Effective from 2 September 2024

Cochlear Limited Announces Executive Changes

Cochlear Limited (ASX:COH) acquired Oticon Medical A/s from Demant A/S (CPSE:DEMANT).

Cochlear Limited Announces Company Secretary Changes

Cochlear Limited Receives Fda Clearance to Lower the Age for the Osia System to 5-Year-Old

Upcoming dividend of AU$2.00 per share

First half 2024 earnings released: EPS: AU$2.92 (vs AU$2.15 in 1H 2023)

Upcoming dividend of AU$1.75 per share at 1.2% yield

Cochlear Limited Introduces Next Generation Cochlear Osia System with Ability to Have MRI at 3.0 T

Cochlear Limited to Report Fiscal Year 2024 Results on Aug 15, 2024

Full year 2023 earnings released: EPS: AU$4.57 (vs AU$4.40 in FY 2022)

Cochlear Limited Announces Andrew Denver, Non-Executive Director Intention to Retire At AGM to Be Held on 17 October 2023

Upcoming dividend of AU$1.55 per share at 1.3% yield

Cochlear Limited Provides Earnings Outlook for the Year 2023

Cochlear Limited (ASX:COH) announces an Equity Buyback for AUD 75 million worth of its shares.

Cochlear Limited, Annual General Meeting, Oct 17, 2023

FDA Approves Cochlear Limited's Nucleus 8 Sound Processor, Smaller, Smarter, Better Connected Cochlear Implant Technology

Key Executive recently bought AU$97k worth of stock

Upcoming dividend of AU$1.45 per share

Full year 2022 earnings released: EPS: AU$4.40 (vs AU$4.93 in FY 2021)

Cochlear Announces Final Dividend Payable on 17 October 2022

Cochlear Limited Appoints Karen Penrose to Board, Effective on 1 July 2022

Cochlear Limited, Annual General Meeting, Oct 18, 2022

Cochlear Limited to Report First Half, 2023 Results on Feb 15, 2023

Upcoming dividend of AU$1.55 per share

First half 2022 earnings: EPS in line with analyst expectations despite revenue beat

Cochlear Limited Announces Interim Dividend Expected to Be Payable on 21 April 2022

FDA Approves Cochlear Nucleus Implants for Unilateral Hearing Loss/Single-Sided Deafness

Independent Non-Executive Director recently bought AU$56k worth of stock

Cochlear Limited Advises of US Patent Infringement Complaint

Upcoming dividend of AU$1.40 per share

Sensorion and Cochlear to Begin First Clinical Trial of SENS-401 for Hearing Preservation in Combination with Cochlear Implantation

Independent Non-Executive Director recently bought AU$94k worth of stock

Independent Chairman Roderic Holliday-Smith has left the company

Full year 2021 earnings released: EPS AU$4.97 (vs AU$4.00 loss in FY 2020)

Cochlear Limited Provides Earnings Guidance for the Fiscal Year 2022

Non-Executive Independent Director Abbas Hussain has left the company

New Cochlear CoPilot app to help adults improve hearing outcomes through skills training

Upcoming Dividend of AU$1.15 Per Share

Cochlear Receives FDA Clearance of Baha 6 Max, Industry's Smallest 55 dB Sound Processor Now with Direct Android Streaming

Independent Non-Executive Director recently bought AU$164k worth of stock

Cochlear Limited Receives US Food and Drug Administration Approval for Baha 6 Max Sound Processor

First half 2021 earnings released: EPS AU$3.59 (vs AU$2.73 in 1H 2020)

Revenue beats expectations

Cochlear Limited Appoints Stu Sayers as Chief Financial Officer

New 90-day low: AU$189

New 90-day low: AU$194

Cochlear Limited Appoints Stu Sayers as Acting CFO

New 90-day high: AU$233

Cochlear Limited Appoints Stephen Mayne as Director

Cochlear Limited to Report Fiscal Year 2021 Results on Aug 20, 2021

Cochlear Limited to Report Fiscal Year 2020 Results on Aug 18, 2020

Analisi delle retribuzioni degli amministratori delegati

AMMINISTRATORE DELEGATO

Mandato

Compensazione

Gruppo dirigente

Durata media

Membri del Consiglio di amministrazione

Durata media

Età media